Sysmex (OTCMKTS:SSMXY) Issues Earnings Results

Sysmex (OTCMKTS:SSMXY) posted its quarterly earnings results on Wednesday. The company reported $0.17 earnings per share for the quarter, Zacks reports. Sysmex updated its FY 2024 guidance to 0.580-0.580 EPS.

Sysmex Stock Performance

OTCMKTS:SSMXY opened at $18.22 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. Sysmex has a 1 year low of $14.38 and a 1 year high of $28.58. The stock’s 50 day simple moving average is $18.92 and its two-hundred day simple moving average is $19.02. The company has a market cap of $11.47 billion, a price-to-earnings ratio of 36.91 and a beta of 0.90.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.